Thomas McDonald
Oral and Maxillofacial Surgery · Florence, SCNPI 1932113180
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.1%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. Straumann USA LLC accounts for 73.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,094 and has fallen 92.1% since, to $87 in 2025.
Across 38 payments — averaging $65.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$2K
- Zimvie Inc.$390
- Zimmer Biomet$193
- Lilly USA, LLC$39
- Kls-martin L.p.$26
- Southern Anesthesia & Surgical, Inc (dba ACE Southern)$14
- plus $13 from 1 others
What the payments were for
- Travel & lodging$67727%
- Food & beverage$1,12645%
- Education$502%
- Gifts$64326%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 13 | $1,822 |
| Zimvie Inc. | 12 | $390 |
| Zimmer Biomet | 7 | $193 |
| Lilly USA, LLC | 2 | $39 |
| Kls-martin L.p. | 2 | $26 |
| Southern Anesthesia & Surgical, Inc (dba ACE Southern) | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Diem2-RevitaliZe$105
How this compares
$2,497 in reported general payments places this provider in the 75th percentile of 115 oral and maxillofacial surgery providers in South Carolina.
See all oral and maxillofacial surgery providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 145 | $430 |
| Chlorhexidine Gluconate | 89 | $396 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $347 |
| Amoxicillin | 140 | $322 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 134 | $289 |
| Gabapentin | 12 | $122 |
| Clindamycin Hcl | 17 | $112 |
| Tramadol Hcl | 19 | $32 |
| Ondansetron Hcl | 14 | $22 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Florence
- Albert OliphantCharleston$18K
- R Jason HehrNorth Charleston$13K
- Jonathan BeanColumbia$13K
- Daniel LeachNorth Charleston$10K
- Edward StraussCharleston$10K
- Jeffery DootsonColumbia$8K
- Stephen ClaryColumbia$8K
- Ashley TankersleyGreenville$7K
- James WilsonGreenville$6K
- Aaron SarathyBeaufort$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.